Bioinformatics, Biotech, Cancer therapeutics, Cleantech, Clinical trials, Diagnostics, Digital Health, Drug Delivery, Drug Discovery, Fitness, Food tech, Genomics, Health tech, Immunology, Medical Device, Medicine, Nanotechnology, Neurosciences, Oncology, Personalised medicine, Predictive medicine, Therapeutics, Wearables, biochemistry, cell biology, embryology, genetics, molecular biology, antibodies, biosimilars, cell therapy, gene therapy, molecular diagnostics, peptides, small molecules, molecular diagnostics, nucleic acid drugs, peptides, proteins, stem cells, vaccines
Dr. Zia Choudhry is a pharmaceutical executive, medical strategist, clinical researcher, medical specialist (psychiatry, neurology, pain, & oncology), personalized health expert, & medical geneticist. He is committed to development of Drugs, Devices & Diagnostics improving patients’ lives.
Presently, Dr. Choudhry is the Global Medical Director at Sanofi-Genzyme. He is responsible for developing global medical affairs strategy for inline and pipeline products & leads the Medical teams. As a Physician Executive, he has led Biopharmaceutical, PGx, & medical device product launches, pivotal clinical trials, & communication platforms. He has published in prestigious scientific journals and conducted high-impact Advisory boards. Additionally, he conducts CMEs for physicians and serves on the boards of two non-profit organizations.
Prior to Sanofi, Dr. Choudhry has worked for 17+ years in clinical care, medical affairs and research leadership positions and led teams for top tier organizations, including Purdue, Genomind and Pfizer.
Dr. Choudhry received Medical Degree from University of Karachi & pursued an Internal/Family Medicine residency. He also holds a Master of Health Informatics from SZAB Institute of Science & Technology; a Master of Business Administration from Al-Khair University; a Master of Sciences in Psychiatry, a Post Graduate Certificate in Sleep Medicine, & a Doctorate of Philosophy in Human Genetics, from McGill University, Canada.
Biomarker Research & Discovery
Personalized & Digital Medicine
Clinical Development, Medical Affairs & Business Development
Clinical Neurosciences (Neurology, Psychiatry & Pain), Rare Diseases & Oncology
Epidemiology, Big Data & Predictive Analytics
Clinical Trials (Phases I -IV), RWE & HEOR Studies
Pharmaceutical Strategy, Market Access & Commercialization
Patient Safety, Risk Management & Adverse Events
Medical Writing, Clinical training, CME & Grants